Back
Eli Lilly & Co. Vs. Novo Nordisk A/S Sector Stock Comparison
Buy
84
LLY
Eli Lilly & Co.
Last Price:
$1,077.74
Seasonality Move:
2.87%
Sell
46
NVO
Novo Nordisk A/S
Last Price:
$52.40
Seasonality Move:
3.96%
Buy
84
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,077.75. The Score for LLY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
46
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $52.40. The Score for NVO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,077.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $52.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight buying pressure.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.57 | Buy |
| Relative Strength Index (14 RSI): | 64.35 | Buy |
| Chaikin Money Flow: | 450348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1016.15 - 1081.85) | Buy |
| Bollinger Bands (100): | (720.91 - 1001.35) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 62.03 | Buy |
| Chaikin Money Flow: | 750314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.8 - 50.38) | Buy |
| Bollinger Bands (100): | (48.35 - 56.99) | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1065.91 | Buy |
| 20-day SMA: | 1041.88 | Buy |
| 50-day SMA: | 975.91 | Buy |
| 200-day SMA: | 822.8 | Buy |
| 8-day EMA: | 1065.22 | Buy |
| 20-day EMA: | 1044.88 | Buy |
| 50-day EMA: | 984.07 | Buy |
| 200-day EMA: | 861.04 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.64 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 49.54 | Buy |
| 200-day SMA: | 60.31 | Sell |
| 8-day EMA: | 50.42 | Buy |
| 20-day EMA: | 49.45 | Buy |
| 50-day EMA: | 50.37 | Buy |
| 200-day EMA: | 62.63 | Sell |
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.85 per share, and an increase next year of $8.98 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.18 per share.
Eli Lilly & Co. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||